{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,7]],"date-time":"2026-10-07T11:52:17Z","timestamp":1791373937118,"version":"4.3.1"},"reference-count":37,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2026,9,1]],"date-time":"2026-09-01T00:00:00Z","timestamp":1788220800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2026,9,1]],"date-time":"2026-09-01T00:00:00Z","timestamp":1788220800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2026,9,1]],"date-time":"2026-09-01T00:00:00Z","timestamp":1788220800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2026,9,1]],"date-time":"2026-09-01T00:00:00Z","timestamp":1788220800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2026,9,1]],"date-time":"2026-09-01T00:00:00Z","timestamp":1788220800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2026,9,1]],"date-time":"2026-09-01T00:00:00Z","timestamp":1788220800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2026,9,1]],"date-time":"2026-09-01T00:00:00Z","timestamp":1788220800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"funder":[{"DOI":"10.13039\/100007048","name":"Mayo Foundation for Medical Education and Research","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100007048","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","surgjournal.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Surgery"],"published-print":{"date-parts":[[2026,9]]},"DOI":"10.1016\/j.surg.2026.110586","type":"journal-article","created":{"date-parts":[[2026,9,1]],"date-time":"2026-09-01T23:58:56Z","timestamp":1788307136000},"page":"110586","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":0,"title":["Association between genotype and long-term risk of reintervention and distant metastases in patients with multiple endocrine neoplasia type 1\u2013associated duodenopancreatic neuroendocrine tumors"],"prefix":"10.1016","author":[{"ORCID":"https:\/\/orcid.org\/0000-0001-9140-6548","authenticated-orcid":false,"given":"Omair A.","family":"Shariq","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sutton","family":"Julsrud","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Geoffrey B.","family":"Thompson","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Thorvardur R.","family":"Halfdanarson","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Trenton R.","family":"Foster","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Benzon M.","family":"Dy","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"suffix":"Jr.","given":"William F.","family":"Young","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Travis J.","family":"McKenzie","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Melanie L.","family":"Lyden","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.surg.2026.110586_bib1","doi-asserted-by":"crossref","first-page":"2","DOI":"10.1016\/j.mce.2013.08.002","article-title":"Multiple endocrine neoplasia type 1 (MEN1) and type 4 (MEN4)","volume":"386","author":"Thakker","year":"2014","journal-title":"Mol Cell Endocrinol"},{"key":"10.1016\/j.surg.2026.110586_bib2","doi-asserted-by":"crossref","DOI":"10.3389\/fendo.2022.1029041","article-title":"Beyond the \"3 Ps\": a critical appraisal of the non-endocrine manifestations of multiple endocrine neoplasia type 1","volume":"13","author":"Waguespack","year":"2022","journal-title":"Front Endocrinol (Lausanne)"},{"key":"10.1016\/j.surg.2026.110586_bib3","doi-asserted-by":"crossref","first-page":"265","DOI":"10.1097\/01.sla.0000197715.96762.68","article-title":"Epidemiology data on 108 MEN 1 patients from the GTE with isolated nonfunctioning tumors of the pancreas","volume":"243","author":"Triponez","year":"2006","journal-title":"Ann Surg"},{"key":"10.1016\/j.surg.2026.110586_bib4","doi-asserted-by":"crossref","first-page":"1094","DOI":"10.1097\/SLA.0000000000003162","article-title":"Metastatic potential and survival of duodenal and pancreatic tumors in multiple endocrine neoplasia type 1: a GTE and AFCE cohort study (Groupe d'\u00e9tude des Tumeurs Endocrines and Association Francophone de Chirurgie Endocrinienne)","volume":"272","author":"Vinault","year":"2020","journal-title":"Ann Surg"},{"key":"10.1016\/j.surg.2026.110586_bib5","doi-asserted-by":"crossref","first-page":"641","DOI":"10.4158\/EP161639.OR","article-title":"Prognostic factors for survival of MEN1 patients with duodenopancreatic tumors metastatic to the liver: results from the dmsg","volume":"23","author":"Conemans","year":"2017","journal-title":"Endocr Pract"},{"key":"10.1016\/j.surg.2026.110586_bib6","doi-asserted-by":"crossref","first-page":"609","DOI":"10.1159\/000511791","article-title":"Multiple endocrine neoplasia type 1 and the pancreas: diagnosis and treatment of functioning and non-functioning pancreatic and duodenal neuroendocrine neoplasia within the MEN1 syndrome\u2013an international consensus statement","volume":"111","author":"Niederle","year":"2021","journal-title":"Neuroendocrinology"},{"key":"10.1016\/j.surg.2026.110586_bib7","doi-asserted-by":"crossref","first-page":"723","DOI":"10.1016\/j.surg.2022.04.011","article-title":"Clinical features and postoperative survival in patients with sporadic versus multiple endocrine neoplasia type 1-related pancreatic neuroendocrine tumors: an international cohort study","volume":"172","author":"Bergquist","year":"2022","journal-title":"Surgery"},{"key":"10.1016\/j.surg.2026.110586_bib8","doi-asserted-by":"crossref","first-page":"699","DOI":"10.1016\/S2213-8587(25)00119-6","article-title":"Multiple endocrine neoplasia type 1 (MEN1): recommendations and guidelines for best practice","volume":"13","author":"Brandi","year":"2025","journal-title":"Lancet Diabetes Endocrinol"},{"key":"10.1016\/j.surg.2026.110586_bib9","doi-asserted-by":"crossref","first-page":"7808","DOI":"10.1245\/s10434-022-12350-1","article-title":"Long-term outcomes for patients with multiple endocrine neoplasia type 1 and duodenopancreatic neuroendocrine neoplasms","volume":"29","author":"Liu","year":"2022","journal-title":"Ann Surg Oncol"},{"key":"10.1016\/j.surg.2026.110586_bib10","doi-asserted-by":"crossref","first-page":"3795","DOI":"10.1210\/jc.2017-00372","article-title":"Long-term natural course of small nonfunctional pancreatic neuroendocrine tumors in MEN1\u2014Results from the Dutch MEN1 study group","volume":"102","author":"Pieterman","year":"2017","journal-title":"J Clin Endocrinol Metab"},{"key":"10.1016\/j.surg.2026.110586_bib11","doi-asserted-by":"crossref","first-page":"199","DOI":"10.1111\/cen.13264","article-title":"Long-term outcomes in patients with multiple endocrine neoplasia type 1 and pancreaticoduodenal neuroendocrine tumours","volume":"86","author":"Donegan","year":"2017","journal-title":"Clin Endocrinol (Oxf)"},{"key":"10.1016\/j.surg.2026.110586_bib12","doi-asserted-by":"crossref","first-page":"315","DOI":"10.1016\/j.soc.2022.10.008","article-title":"Multiple endocrine neoplasia type 1 syndrome pancreatic neuroendocrine tumor genotype\/phenotype: is there any advance on predicting or preventing?","volume":"32","author":"Ramamoorthy","year":"2023","journal-title":"Surg Oncol Clin N Am"},{"key":"10.1016\/j.surg.2026.110586_bib13","doi-asserted-by":"crossref","first-page":"2990","DOI":"10.1210\/jc.2012-1230","article-title":"Clinical practice guidelines for multiple endocrine neoplasia type 1 (MEN1)","volume":"97","author":"Thakker","year":"2012","journal-title":"J Clin Endocrinol Metab"},{"key":"10.1016\/j.surg.2026.110586_bib14","doi-asserted-by":"crossref","first-page":"5658","DOI":"10.1210\/jcem.86.12.8070","article-title":"Guidelines for diagnosis and therapy of MEN type 1 and type 2","volume":"86","author":"Brandi","year":"2001","journal-title":"J Clin Endocrinol Metab"},{"key":"10.1016\/j.surg.2026.110586_bib15","series-title":"Endocrine and Neuroendocrine Tumours","year":"2025"},{"key":"10.1016\/j.surg.2026.110586_bib16","doi-asserted-by":"crossref","first-page":"4","DOI":"10.1038\/ng.3466","article-title":"Exploring genomic alteration in pediatric cancer using ProteinPaint","volume":"48","author":"Zhou","year":"2016","journal-title":"Nat Genet"},{"key":"10.1016\/j.surg.2026.110586_bib17","doi-asserted-by":"crossref","first-page":"143","DOI":"10.1016\/S0092-8674(00)80967-8","article-title":"Menin interacts with the AP1 transcription factor JunD and represses JunD-activated transcription","volume":"96","author":"Agarwal","year":"1999","journal-title":"Cell"},{"key":"10.1016\/j.surg.2026.110586_bib18","doi-asserted-by":"crossref","first-page":"4917","DOI":"10.1038\/sj.onc.1204529","article-title":"The tumor suppressor protein menin interacts with NF-kappaB proteins and inhibits NF-kappaB-mediated transactivation","volume":"20","author":"Heppner","year":"2001","journal-title":"Oncogene"},{"key":"10.1016\/j.surg.2026.110586_bib19","doi-asserted-by":"crossref","first-page":"40267","DOI":"10.1074\/jbc.M401312200","article-title":"Menin is required for bone morphogenetic protein 2- and transforming growth factor beta-regulated osteoblastic differentiation through interaction with Smads and Runx2","volume":"279","author":"Sowa","year":"2004","journal-title":"J Biol Chem"},{"key":"10.1016\/j.surg.2026.110586_bib20","doi-asserted-by":"crossref","first-page":"587","DOI":"10.1016\/S1097-2765(04)00081-4","article-title":"Menin associates with a trithorax family histone methyltransferase complex and with the hoxc8 locus","volume":"13","author":"Hughes","year":"2004","journal-title":"Mol Cell"},{"key":"10.1016\/j.surg.2026.110586_bib21","doi-asserted-by":"crossref","first-page":"6791","DOI":"10.1158\/0008-5472.CAN-04-0724","article-title":"Functional interaction between tumor suppressor menin and activator of S-phase kinase","volume":"64","author":"Schnepp","year":"2004","journal-title":"Cancer Res"},{"key":"10.1016\/j.surg.2026.110586_bib22","doi-asserted-by":"crossref","first-page":"22","DOI":"10.1002\/humu.20605","article-title":"Multiple endocrine neoplasia type 1 (MEN1): analysis of 1336 mutations reported in the first decade following identification of the gene","volume":"29","author":"Lemos","year":"2008","journal-title":"Hum Mutat"},{"key":"10.1016\/j.surg.2026.110586_bib23","doi-asserted-by":"crossref","first-page":"753","DOI":"10.1210\/jc.2018-01170","article-title":"UMD-MEN1 database: an overview of the 370 MEN1 variants present in 1676 patients from the French population","volume":"104","author":"Romanet","year":"2018","journal-title":"J Clin Endocrinol Metab"},{"key":"10.1016\/j.surg.2026.110586_bib24","doi-asserted-by":"crossref","DOI":"10.1172\/jci.insight.176993","article-title":"Genotype-phenotype correlation in multiple endocrine neoplasia type 1","volume":"10","author":"Worthy","year":"2025","journal-title":"JCI Insight"},{"key":"10.1016\/j.surg.2026.110586_bib25","doi-asserted-by":"crossref","first-page":"134","DOI":"10.1016\/j.pan.2024.11.020","article-title":"Genotype-based prognosis prediction for MEN1-related pancreatic neuroendocrine tumors in Korean patients a single-center retrospective study","volume":"25","author":"Kim","year":"2025","journal-title":"Pancreatology"},{"key":"10.1016\/j.surg.2026.110586_bib26","doi-asserted-by":"crossref","first-page":"212","DOI":"10.1016\/j.surg.2017.04.044","article-title":"Genotype-phenotype pancreatic neuroendocrine tumor relationship in multiple endocrine neoplasia type 1 patients: a 23-year experience at a single institution","volume":"163","author":"Christakis","year":"2018","journal-title":"Surgery"},{"key":"10.1016\/j.surg.2026.110586_bib27","doi-asserted-by":"crossref","first-page":"958","DOI":"10.1067\/msy.2000.109727","article-title":"Pancreaticoduodenal endocrine tumors in multiple endocrine neoplasia type 1: surgery or surveillance?","volume":"128","author":"Bartsch","year":"2000","journal-title":"Surgery"},{"key":"10.1016\/j.surg.2026.110586_bib28","doi-asserted-by":"crossref","DOI":"10.3389\/fendo.2021.681013","article-title":"A direct comparison of patients with hereditary and sporadic pancreatic neuroendocrine tumors: evaluation of clinical course, prognostic factors and genotype\u2013phenotype correlations","volume":"12","author":"Soczomski","year":"2021","journal-title":"Front Endocrinol (Lausanne)"},{"key":"10.1016\/j.surg.2026.110586_bib29","doi-asserted-by":"crossref","first-page":"83","DOI":"10.1186\/1471-2156-9-83","article-title":"Comparison of nonsense-mediated mRNA decay efficiency in various murine tissues","volume":"9","author":"Zetoune","year":"2008","journal-title":"BMC Genet"},{"key":"10.1016\/j.surg.2026.110586_bib30","doi-asserted-by":"crossref","first-page":"829","DOI":"10.1016\/j.surg.2007.09.010","article-title":"Pancreatoduodenal surgery in patients with multiple endocrine neoplasia type 1: operative outcomes, long-term function, and quality of life","volume":"142","author":"You","year":"2007","journal-title":"Surgery"},{"key":"10.1016\/j.surg.2026.110586_bib31","doi-asserted-by":"crossref","first-page":"643","DOI":"10.1007\/s00268-006-0360-y","article-title":"Management of pancreatic endocrine tumors in multiple endocrine neoplasia type 1","volume":"30","author":"Kouvaraki","year":"2006","journal-title":"World J Surg"},{"key":"10.1016\/j.surg.2026.110586_bib32","doi-asserted-by":"crossref","first-page":"495","DOI":"10.1046\/j.1365-2796.1998.00307.x","article-title":"Current concepts in the surgical management of multiple endocrine neoplasia type 1 pancreatic-duodenal disease. Results in the treatment of 40 patients with Zollinger\u2013Ellison syndrome, hypoglycaemia or both","volume":"243","author":"Thompson","year":"1998","journal-title":"J Intern Med"},{"key":"10.1016\/j.surg.2026.110586_bib33","doi-asserted-by":"crossref","first-page":"1205","DOI":"10.1016\/j.surg.2004.06.049","article-title":"The surgical management of MEN-1 pancreatoduodenal neuroendocrine disease","volume":"136","author":"Hausman","year":"2004","journal-title":"Surgery"},{"key":"10.1016\/j.surg.2026.110586_bib34","doi-asserted-by":"crossref","first-page":"352","DOI":"10.1097\/SLA.0000000000002050","article-title":"Early and late complications after surgery for MEN1-related nonfunctioning pancreatic neuroendocrine tumors","volume":"267","author":"Nell","year":"2018","journal-title":"Ann Surg"},{"key":"10.1016\/j.surg.2026.110586_bib35","doi-asserted-by":"crossref","first-page":"552","DOI":"10.1007\/s00268-018-4809-1","article-title":"Results of duodenopancreatic reoperations in multiple endocrine neoplasia type 1","volume":"43","author":"Albers","year":"2019","journal-title":"World J Surg"},{"key":"10.1016\/j.surg.2026.110586_bib36","doi-asserted-by":"crossref","first-page":"R145","DOI":"10.1530\/ERC-19-0372","article-title":"Prognostic factors for the outcome of nonfunctioning pancreatic neuroendocrine tumors in MEN1: a systematic review of literature","volume":"27","author":"Sadowski","year":"2020","journal-title":"Endocr Relat Cancer"},{"key":"10.1016\/j.surg.2026.110586_bib37","doi-asserted-by":"crossref","first-page":"158","DOI":"10.1097\/SLA.0000000000002191","article-title":"Long-term follow-up of MEN1 patients who do not have initial surgery for small \u22642 cm nonfunctioning pancreatic neuroendocrine tumors, an AFCE and GTE study: association Francophone de Chirurgie Endocrinienne & Groupe d\u2019Etude des Tumeurs Endocrines","volume":"268","author":"Triponez","year":"2018","journal-title":"Ann Surg"}],"container-title":["Surgery"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0039606026005118?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0039606026005118?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,10,7]],"date-time":"2026-10-07T11:12:43Z","timestamp":1791371563000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0039606026005118"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,9]]},"references-count":37,"alternative-id":["S0039606026005118"],"URL":"https:\/\/doi.org\/10.1016\/j.surg.2026.110586","relation":{},"ISSN":["0039-6060"],"issn-type":[{"value":"0039-6060","type":"print"}],"subject":[],"published":{"date-parts":[[2026,9]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Association between genotype and long-term risk of reintervention and distant metastases in patients with multiple endocrine neoplasia type 1\u2013associated duodenopancreatic neuroendocrine tumors","name":"articletitle","label":"Article Title"},{"value":"Surgery","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.surg.2026.110586","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2026 Elsevier Inc. All rights are reserved, including those for text and data mining, AI training, and similar technologies.","name":"copyright","label":"Copyright"}],"article-number":"110586"}}